World J Gastroenterol. 2010 May 28; 16(20): 2549-2553.
Published online 2010 May 28. doi: 10.3748/wjg.v16.i20.2549.
©2010 Baishideng. All rights reserved.
XbaI polymorphisms of apolipoprotein B gene: Another risk factor of gallstone formation after radical gastrectomy
Feng-Lin Liu, Wen-Bin Lu, Wei-Xin Niu, Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Received January 21, 2010; Revised March 12, 2010; Accepted March 19, 2010;
AIM: To prospectively investigate the association between the XbaI polymorphisms of apolipoprotein B (APOB) gene and gallstone formation following gastrectomy.
METHODS: The study was conducted between January 2005 and December 2006. A total of 186 gastric cancer patients who had undergone radical gastrectomy were grouped according to XbaI polymorphisms of APOB gene (X+X- group, n = 24 and X-X- group, n = 162) and compared. The XbaI polymorphisms of APOB gene were detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
RESULTS: The incidence of gallstone was significantly higher in the X+X- group than in the X-X- group [54.2% vs 9.3%, RR = 5.85 (2.23-15.32), P < 0.001]. The serum levels of total cholesterol (TC) and low-density lipoprotein (LDL) were higher in the X+X- than in the X-X- group (4.02 ± 1.12 vs 3.48 ± 0.88, P = 0.004 before surgery and 3.88 ± 1.09 vs 3.40 ± 0.86, P = 0.008 after surgery). LDL was 2.21 ± 0.96 vs 1.89 ± 0.84 (P = 0.042) before surgery and 2.09 ± 0.95 vs 1.72 ± 0.85 (P = 0.029) after surgery in the two groups. No relationship was found between XbaI polymorphisms and gallbladder motility.
CONCLUSION: In Chinese patients after radical gastrectomy, X+ allele of APOB gene is another risk factor for the development of gallstone besides the gallbladder motility disorder after surgery.
Keywords: Gastric cancer, Gastrectomy, Gallstone, Apolipoprotein B gene, Polymorphism
The incidence of gallstones is higher in patients after radical gastrectomy than in the general population[1
]. The current literature suggests that this higher incidence is related to gallbladder motility disorder after surgery resulting from severance of the vagus nerve, non-physiological reconstruction of the gastrointestinal tract and lymph node dissection[2-5
]. However, it is also observed in clinical practice that following the same type of surgery on patients with the same stage of gastric cancer, some of them do and the others do not develop gallstones. This suggests that besides gallbladder dysmotility, there are some possible inherent factors of gallstone formation after gastrectomy. In recent years, several studies have reported that polymorphisms in the apolipoprotein B (APOB
) gene were associated with gallstone diseases[6,7
]. Apolipoprotein B is a key protein in lipid metabolism. It plays an important role in the homeostasis of low-density lipoprotein (LDL) cholesterol in plasma serving as a ligand for receptor-mediated endocytosis of LDL. Several polymorphic forms of APOB
alleles have been reported to be associated with disorders like coronary heart disease and non-insulin dependent diabetes mellitus[8
]. The APOB
I polymorphism has been found to be associated with increased serum lipids. Genetic polymorphisms in the APOB
gene have also been reported to be associated with susceptibility to cholesterol gallstones[9
]. However, the effects of APOB
I gene polymorphism in patients who had undergone radical gastrectomy for gastric cancer without any previous history of cholelithiasis, abnormal gallbladders motility, diabetes, hyperlipidemia, hyperparathyroidism and other metabolic disorders is unknown. The present study prospectively investigated the association between the Xba
I polymorphisms of APOB
gene and gallstone formation after radical gastrectomy.
MATERIALS AND METHODS
The study enrolled 206 patients who underwent radical gastrectomy for gastric cancer in Zhongshan Hospital between January 2005 and December 2006. The inclusion criteria included age less than 60 years; biopsy proven gastric cancer; normal gallbladder motility; no gallstone or other hepatobiliary system diseases, no metabolic disorders and important organs dysfunction. To avoid biases, all patients were operated upon by the same surgical team with D2 dissection. Complete data were available for only 186 patients as 20 patients were lost to follow-up (3 patients in X+X- group and 17 patients in X-X- group). These patients were grouped according to XbaI polymorphisms of APOB gene. For analyzing the effects of XbaI polymorphisms, blood was also collected before and 6 mo after gastrectomy. The serum lipids, lipoproteins and apolipoproteins were determined. The levels of total cholesterol (TC), LDL and APOB were tested by biochemical autoanalyser (HITACHI7600). The gallbladder motility was examined by detecting gallbladder emptying fraction (GBEF) using nuclide imaging before and 6 mo after gastrectomy. Gallstone formation was determined by periodic ultrasonography after gastrectomy.
Informed consent was obtained from all patients, and the study was approved by the ethics committee of the hospital.
Determination of DNA polymorphism
Leukocyte genomic DNA was extracted from 5 mL of peripheral blood by TianGen Genetic DNA Kit (TianGen Biotech Co., Ltd.). The desired segments were amplified by PCR using the APOB XbaI protocols with the primers: 5’(5’GGAGACTATTCAGAAGCTAA3’) and 3’(3’GAAGAGCCTGAAGACTGACT5’). The final amplification products were submitted to digestion with the restriction enzymes (XbaI) and the variations were visualized after electrophoresis on 1.5% agarose gel with ethidium bromide under ultra-violet light, followed by photographic documentation. PCR cycle for amplification of APOB gene was performed at 95°C for 5 min followed by 95°C for 45 s, annealing at 58°C for 45 s and extension at 72°C for 45 s in 33 cycles. A final extension was conducted for 10 min at 72°C. The products were digested by XbaI restriction enzyme at 37°C for 12 h.
Data are expressed as the means ± SD. Means of age, body mass index (BMI), TC, LDL and APOB in different groups were compared using Student’s t test. Gender, stage, types of gastrectomy and reconstruction were compared using χ2 test. The differences between each genotype of XbaI polymorphisms and the incidence of gallstones were assessed by Fisher’s exact test. Interaction between XbaI polymorphisms and gallbladder motility in the development of gallstone after gastrectomy was estimated by logistic regression analysis. SPSS statistical software, version 15.0 for Windows was used for all analyses. P < 0.05 was considered statistically significant.
Demographic data of X+X- group and X-X- group
The frequencies of X+X- and X-X- in 186 patients were 24 (13%) and 162 (87%), respectively. No genotype with X+X+ was detected in the study. Demographic data of X+X- group and X-X- groups are shown in Table . The median follow-up time was 28 mo (range: 24-32 mo). The mean age and BMI at the time of gastrectomy was 56.1 ± 8.2 years (range: 38-80 years) and 21.9 ± 1.8 kg/m2 (range: 19.2-25.1 kg/m2), respectively. With regard to type of gastrectomy, 7 (4%), 162 (87%), and 17 (9%) patients underwent a proximal, distal and total gastrectomy, respectively. Age and BMI did not differ significantly between the X+X- and X-X- groups. With respect to TMN stage, gallbladders motility after surgery, types of gastrectomy and reconstruction, there were no significant differences between the two groups (Table ).
Demographic data of 186 gastric cancer patients who underwent gastrectomy with D2 dissection in the X+X- and X-X- groups (mean ± SD) n (%)
Gallstone formation after radical gastrectomy in X+X- and X-X- groups
Of the 186 patients, 28 (15.1%; 13 in X+X- group, 15 in X-X- group) developed gallstones with in a mean follow-up period of 28.4 ± 2.7 mo. The incidence of gallstone formation was significantly higher in the X+X- group than in the X-X- group (54.2% vs 9.3%, relative risk 5.85, 95% CI: 2.23-5.32, P < 0.001). The time period from gastrectomy to detection of the gallstones ranged from 6 to 32 mo with a median of 20 mo. The timing of gallstones formation showed no difference between the two groups (Table ). For further analysis, whether interaction existed between XbaI polymorphisms and gallbladder motility in the development of gallstone after gastrectomy was estimated by logistic regression. As a result, no interaction effect of XbaI polymorphisms was found with gallbladder motility (Table ). To analyze the higher incidence of gallstone in X+X- group, the serum concentrations of TC, LDL and APOB were compared between the two groups (Table ). The serum levels of TC and LDL were significantly higher in X+X- group than in X-X- group both before and after surgery, but there was no statistical difference in APOB values between the two groups.
Gallstone formation after radical gastrectomy
Association of XbaI genotypes with gallstone after gastrectomy, stratified by gallbladder motility status
Serum levels of TC, LDL and APOB in X+X- and X-X- groups (mean ± SD)
Formation of gallstones after radical gastrectomy is the result of a very complex interaction of various factors. Destruction of neural structures, such as the vagal nerves, represents one well-known risk factor[2,10,11
]. It is speculated that complete amputation of the vagal trunk with dissection of the esophagus (as in total gastrectomy) has a great influence on the contractile ability of the gallbladder. A previous experimental study showed that gastrectomy abolishes phasic contraction of the gallbladder, resulting in an absence of agitation of the gallbladder bile and mixing of gallbladder bile with fresh hepatic bile, increasing the propensity for salt precipitation and gallstone formation[12
]. The type of reconstruction is also closely related to gallstone formation because the passage of food through the duodenum stimulates a variety of hormonal secretions such as cholecystokinin[13,14
] and this hormone causes contraction of the gallbladder through the hormonal regulation system. It is postulated that exclusion of the duodenum leads to changes in the pattern of cholecystokinin secretion, resulting in decreased gallbladder contraction and an increased risk of gallstone formation[15
Almost all previous studies have attributed gallstone formation to gallbladder motility disorder after radical gastrectomy. However, it is known from clinical experience that after the same type of surgery is performed on patients with the same stage of gastric cancer, some of them do and the others do not develop gallstones. In the present study, of 114 patients with abnormal gallbladder motility after surgery, 24 patients (21%) developed gallstones and the others did not. It suggests that the theory of gallbladder motility disorder cannot completely explain gallstone formation after radical gastrectomy. The present study showed that the incidence of gallstone formation was significantly higher in the X+X- group than in the X-X- group (54.2% vs 9.3%), RR 5.85 (2.23-15.32), suggesting that the X+X- genotype may be another risk factor in gallstone formation after radical gastrectomy besides gallbladder motility disorder. Furthermore, we found that X+X- genotype had no interaction effect with gallbladder motility.
I RFLP-PCR in exon 26 of the APOB
gene involves the 2488th nucleotide (ACC→ACT). The presence of thymine creates a restriction site for the Xba
I enzyme characterizing the X+
allele, whereas its absence determines the X-
allele. These are synonymous variations and so they do not affect the amino acid sequence of APOB
]. Hegele et al[18
] suggested that the allelic frequencies varied between races or within genetic subgroups of a single race. Caucasians have a much higher frequency of X+
allele than Chinese. In our study, the frequency of X+
allele in Chinese population was 13% similar to other regional reports and much lower than that reported in Caucasians, South Asians and Brazilians[8,19-21
]. Law et al[22
] and Rajput-Williams et al[23
] also found a positive association between the X+
allele and cholesterol concentration, whereas others did not demonstrate such correlation[24,25
]. In the present study, we observed that in Chinese population, the serum levels of TC and LDL were significantly higher in X+
group than in X-
group both before and after gastrectomy, but no statistical difference was found in APOB values between the two groups. Since the X+
variations are synonymous, the APOB concentration showed no difference between X+
groups. It is possible that the X+
allele is in linkage disequilibrium with an unknown variation in the APOB
gene or with a variation in another gene that influences the levels of TC and LDL, resulting in an increased saturation of bile cholesterol, leading to the gallstone formation[26,27
In conclusion, the X+ allele of APOB gene in Chinese patients is another important risk factor of gallstone formation after radical gastrectomy. Since this is the first report in a relatively small cohort, the findings should be validated in more independent studies.
The cause of higher incidence of gallstone after radical gastrectomy is very complex. Besides the gallbladder motility disorder, XbaI polymorphisms of apolipoprotein B (APOB) gene may be associated with gallstone development.
APOB is a key protein in lipid metabolism. However, the effects of APOB-XbaI gene polymorphism on patients who underwent radical gastrectomy for gastric cancer are unknown. In this study, the authors demonstrate that X+ allele of APOB gene is an important risk factor of gallstone formation after gastrectomy.
Innovations and breakthroughs
Previous studies have attributed higher incidence of gallstone after radical gastrectomy to gallbladder motility disorder. This is the first study to report the relationship between genetic factor (APOB-XbaI gene polymorphism) and gallstone formation in gastrectomized patients.
It is important to screen the high-risk group of gallstone in patients who underwent radical gastrectomy in order to prevent the gallstone formation after surgery.
This is a small but interesting study with a reasonable rationale - examining whether a suspected genetic risk factor for gallstones increases the risk of gallstones after gastrectomy (which is a known major risk factor for gallstones). The authors indicated X allele of APOB gene is another risk factor for development of gallstone formation after radical gastrectomy. This present data is clear and interesting.
Majoor CL, Suren TJ. Gall-bladder complications following resection of the stomach for peptic ulcer. Br Med J.
Rehnberg O, Haglund U. Gallstone disease following antrectomy and gastroduodenostomy with or without vagotomy. Ann Surg.
Inoue K, Fuchigami A, Higashide S, Sumi S, Kogire M, Suzuki T, Tobe T. Gallbladder sludge and stone formation in relation to contractile function after gastrectomy. A prospective study. Ann Surg.
Kodama I, Yoshida C, Kofuji K, Ohta J, Aoyagi K, Takeda J. Gallstones and gallbladder disorder after gastrectomy for gastric cancer. Int Surg.
Akatsu T, Yoshida M, Kubota T, Shimazu M, Ueda M, Otani Y, Wakabayashi G, Aiura K, Tanabe M, Furukawa T. Gallstone disease after extended (D2) lymph node dissection for gastric cancer. World J Surg.
Lammert F, Sauerbruch T. Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol.
Wang HH, Wang DQ. Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine. Hepatology.
Mittal B, Mittal RD. Genetics of gallstone disease. J Postgrad Med.
Han T, Jiang Z, Suo G, Zhang S. Apolipoprotein B-100 gene Xba I polymorphism and cholesterol gallstone disease. Clin Genet.
Csendes A, Larach J, Godoy M. Incidence of gallstones development after selective hepatic vagotomy. Acta Chir Scand.
Nabae T, Yokohata K, Otsuka T, Inoue K, Yamaguchi K, Chijiiwa K, Tanaka M. Effect of truncal vagotomy on sphincter of oddi cyclic motility in conscious dogs. Ann Surg.
Ura K, Sarna SK, Condon RE. Antral control of gallbladder cyclic motor activity in the fasting state. Gastroenterology.
Pezzolla F, Lantone G, Guerra V, Misciagna G, Prete F, Giorgio I, Lorusso D. Influence of the method of digestive tract reconstruction on gallstone development after total gastrectomy for gastric cancer. Am J Surg.
Bergh C, Sjöstedt S, Hellers G, Zandian M, Södersten P. Meal size, satiety and cholecystokinin in gastrectomized humans. Physiol Behav.
Kobayashi T, Hisanaga M, Kanehiro H, Yamada Y, Ko S, Nakajima Y. Analysis of risk factors for the development of gallstones after gastrectomy. Br J Surg.
Priestley L, Knott T, Wallis S, Powell L, Pease R, Simon A, Scott J. RFLP for the human apolipoprotein B gene: I;BamHI. Nucleic Acids Res.
Blackhart BD, Ludwig EM, Pierotti VR, Caiati L, Onasch MA, Wallis SC, Powell L, Pease R, Knott TJ, Chu ML. Structure of the human apolipoprotein B gene. J Biol Chem.
Hegele RA, Huang LS, Herbert PN, Blum CB, Buring JE, Hennekens CH, Breslow JL. Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction. N Engl J Med.
Pan JP, Chiang AN, Tai JJ, Wang SP, Chang MS. Restriction fragment length polymorphisms of apolipoprotein B gene in Chinese population with coronary heart disease. Clin Chem.
Scartezini M, Zago MA, Chautard-Freire-Maia EA, Pazin-Filho A, Marin-Neto JA, Hotta JK, Nascimento AJ, Dos-Santos JE. The X-X-/E+E+ genotype of the XbaI/EcoRI polymorphisms of the apolipoprotein B gene as a marker of coronary artery disease in a Brazilian sample. Braz J Med Biol Res.
Jiang ZY, Han TQ, Suo GJ, Feng DX, Chen S, Cai XX, Jiang ZH, Shang J, Zhang Y, Jiang Y. Polymorphisms at cholesterol 7alpha-hydroxylase, apolipoproteins B and E and low density lipoprotein receptor genes in patients with gallbladder stone disease. World J Gastroenterol.
Law A, Wallis SC, Powell LM, Pease RJ, Brunt H, Priestley LM, Knott TJ, Scott J, Altman DG, Miller GJ. Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet.
Rajput-Williams J, Knott TJ, Wallis SC, Sweetnam P, Yarnell J, Cox N, Bell GI, Miller NE, Scott J. Variation of apolipoprotein-B gene is associated with obesity, high blood cholesterol levels, and increased risk of coronary heart disease. Lancet.
Hegele RA, Huang LS, Herbert PN, Blum CB, Buring JE, Hennekens CH, Breslow JL. Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction. N Engl J Med.
Darnfors C, Wiklund O, Nilsson J, Gerard B, Carlsson P, Johansson S, Bondjers G, Bjursell G. Lack of correlation between the apolipoprotein B XbaI polymorphism and blood lipid levels in a Swedish population. Atherosclerosis.
Renges HH, Wile DB, McKeigue PM, Marmot MG, Humphries SE. Apolipoprotein B gene polymorphisms are associated with lipid levels in men of South Asian descent. Atherosclerosis.
Turner PR, Talmud PJ, Visvikis S, Ehnholm C, Tiret L. DNA polymorphisms of the apoprotein B gene are associated with altered plasma lipoprotein concentrations but not with perceived risk of cardiovascular disease: European Atherosclerosis Research Study. Atherosclerosis.